CinnaGen Co.

About Zandoriah®

Zandoriah® (teriparatide) is a prescription treatment designed for adults living with osteoporosis and facing a higher risk of fractures, including postmenopausal women, men with osteoporosis, and patients receiving long-term glucocorticoid therapy.

Explore the Key Details

Zandoriah at a Glance

Indication for Zandoriah

For Postmenopausal Women, Men with Osteoporosis, and People on Long-Term Glucocorticoid Therapy

Bone structure and strength

Supporting Bone Strength and Reducing Osteoporotic Fracture Risk

Clinical studies

Comparable Quality, Safety, and Efficacy to the Reference Product

Production quality

Built on CinnaGen's High Standards of Quality and Excellence

We Make Hope Accessible

We bring high-quality biosimilars to patients who need them, Starting with Zandoriah®. Now treating osteoporosis is more affordable, across 30 European countries.